← Back to Insights
October 28, 2020
Authors
David W. Johnson John Kerins
Topics
Innovation System Dynamics
Channels
4sight Radio & TV Interviews Podcasts

Cain Brothers House Calls Podcast: The Future of Clinical Trials: Decentralized, Diversified, Efficient and Fast

The Future of Clinical Trials: Decentralized, Diversified, Efficient and Fast

The race to develop a COVID-19 vaccine has put the clinical trial process under the microscope. Cain Brothers Managing Director, John Kerins, talks with Dave Johnson about innovations in clinical trials that reduce the barriers to participation, improve the diversity of patient populations, and accelerate the development of safe and effective vaccines. Cain Brothers is a division of KeyBanc Capital Markets.

Listen to this episode on Apple Podcasts, Spotify, and Google Podcasts.  

Read the related commentary here.

About the Authors

David W. Johnson

David Johnson is the CEO of 4sight Health, an advisory company working at the intersection of healthcare strategy, economics, innovation. Johnson is a healthcare thought leader, keynote speaker, and strategic advisor to organizations busting the status-quo to reform our healthcare system. He is the author of Market vs. Medicine: America’s Epic Fight for Better, Affordable Healthcare, and his second book, The Customer Revolution in Healthcare: Delivering Kinder, Smarter, Affordable Care for All (McGraw-Hill 2019). As a speaker, Dave plays the role of rebel, challenger, industry historian, investor and company evaluator to push audiences forward. (Watch bio video.) Johnson applies his 25+ years of investment banking in healthcare to identify ways the healthcare industry must change to deliver better care. He received a Masters in Public Policy from Harvard Kennedy School, an English degree from Colgate University, and served in the African Peace Corp service. Join over 10k+ healthcare executives who read our weekly insights and commentary on www.4sighthealth.com. His third book, Less Healthcare, More Health: The Prescription for a Happier, More Equitable and Productive America, will publish in 2024.

John Kerins

John Kerins is a Director in Cain Brother’s Corporate M&A Advisory practice. Mr. Kerins joined Cain Brothers in 2015 with 10+ years of experience in a variety of merger and acquisition, capital raising, and strategic advisory transactions. Mr. Kerins’ notable transactions since joining Cain Brothers include the minority recapitalization of RedCard by Parthenon Capital Partners, the sale of iCardiac Technologies to ERT, the recapitalization of Steward Health Care System with Medical Properties Trust, the sale of Onlife to Guidewell, Morgan Stanley Capital Partners’ acquisition of Clarity, advising Premier Healthcare Exchange and Pay-Plus Solutions on their merger with Stratose, and BioScrip’s PIPE offering to Coliseum Capital Management. Prior to joining Cain Brothers, Mr. Kerins was a Vice President at Deloitte Corporate Finance LLC, where he focused on mergers, acquisitions, and fairness opinions across a variety of sectors. Mr. Kerins’ prior experience also includes working for McMaster-Carr Supply Company, a privately held distributor, in a variety of management capacities, including operations and sales management. Mr. Kerins earned a BA in Political Science from Kenyon College and an MBA from Fordham University.

Recent Posts

System Dynamics
Podcast: Reimagining Employers’ Role in Healthcare 5/2/24
Will a new task force redefine the role of employers in healthcare finance and delivery? Or will its… Read More
By May 2, 2024
Default Image
Innovation
4sight Friday | April 26, 2024
4sight Friday | Physicians, Pharmacists and Mark Engelen | Medicaid Disenrollment and Health Disparities | Fishing and Healthcare… Read More
By April 26, 2024
Innovation
Podcast: How Healthcare Revolutionaries Think with Mark Engelen
Mark Engelen on Why Doctors Don’t Like Pharmacists Mark Engelen, CEO of RxLive, is doing something most doctors… Read More
By April 23, 2024